scRNAseq - ex vivo and parasite-specific CD4 T cells in controlled human malaria - ruxolitinib phase 1 trial

scRNAseq files CD4 T cells during controled human malaria infection studies - ACTRN12621000866808 - to test the impact of host-directed therapy ruxolitinib when co-administered with anti-malarial treatment. Data is ex vivo CD4 T cells, AIM+ CD4 T cells, with GEX and VDJ data from 10X Chromium 5' analysis. GEX analysis rds files starting with: 3_rux.cd4_rux.aim_merged_forPublication 25_rux.cd4_forpublication 9_rux.aim_SCTbyperson_cluster.id.aim_v2_forPublication.rds TCR analysis rds starting with: rux_comb2.RDS and other files: VDJ_cellranger